You're reading the free version. Trader adds the live tape and alerts.
Start tracking
[ABUS] Disposition Disclosure
Roivant Sciences Ltd. · SEC Form 4 · Filed Oct 5, 2026
Disposition
Calculated transaction value
$44.84M
Roivant Sciences Ltd. Director / Ten Percent Owner
[ABUS]
Arbutus Biopharma Corp
[ABUS]
Transaction date
Oct 1, 2026
Public filing date
Oct 5, 2026
Filing lag
Filed 4 days later
[ABUS] daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 8,967,383 shares @ $5
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001140361-26-038692
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$44.84M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Arbutus Biopharma Corp [ABUS] Current | Disposition | Oct 1, 2026 | $44.84M |